C223 (Alendronate Sodium 35 mg)
Pill with imprint C223 is White, Capsule-shape and has been identified as Alendronate Sodium 35 mg. It is supplied by Cipla USA Inc..
Alendronate is used in the treatment of osteoporosis; prevention of osteoporosis; paget's disease; aseptic necrosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Alendronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C223
Alendronate Sodium
- Imprint:
- C223
- Strength:
- 35 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Bisphosphonates
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Cipla USA Inc.
- National Drug Code (NDC):
- 69097-0223
More about alendronate
- Alendronate Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 42 Reviews
- Drug class: bisphosphonates
Consumer resources
- Alendronate
- Alendronate Effervescent Tablets
- Alendronate Oral Solution
- Alendronate Tablets
- Alendronate (Advanced Reading)
Other brands: Fosamax, Binosto
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
